Skip to main content

Houston Primed for Life Sciences Boom

Published Nov 17, 2022 by A.J. Mistretta

Texas Medical Center Drone Shot

HOUSTON (November 17, 2022) – The Greater Houston Partnership commissioned Newmark Consulting Group to conduct a study, sponsored by San Jacinto College, Lone Star College, Houston Community College, and McCord Development, focused on assessing the Houston region’s existing resources and value proposition in the life sciences industry. 

Findings identified Houston’s industry-leading expertise in cell and gene therapy, biologic drug development, and molecular diagnostics; a continuous flow of new talent from regional universities; an emerging and robust commitment by community colleges to support two-year degree pathways to meet industry demands and the ability for life science companies to grow and thrive in the market. The study also identified strategic next steps for the Houston region to capitalize on these advantages. 

“The Newmark study confirms what we knew to be true about the potential for life sciences growth in Houston,” said Susan Davenport, Chief Economic Development Officer of the Greater Houston Partnership. “The study will help us coalesce our regional partners around a cohesive strategy to grow and expand the industry in Houston.”

Home to nearly 700 life science companies, Houston consistently ranks as a top-15 market for life sciences employment nationwide and first in Texas. Houston benefits from the densest patient population in the world, allowing for transformational clinical applications. With Houston’s robust and diverse workforce, an extensive university ecosystem and education infrastructure, along with world class research institutions, Houston is primed to capture extensive subsector gains. 

Houston ranks second in the nation in clinical trial volume, with more than 4,600 currently active clinical trials, representing 15% of all active U.S. trials. Houston-area institutions received $864.1 million in National Institutes of Health (NIH) grant funding, up 16.3% from 2020. In the last five years, the region received nearly $3.9 billion in NIH funding, an average of $740.7 million per year. Supported by the world-class institutions that comprise the Texas Medical Center and Houston’s sizeable patient population, expansive opportunities exist for commercial synergies with leading healthcare providers in the region. 

As a hub for translational and clinical research and pharmaceutical and medical device manufacturing, Houston is home to more than 26,000 non-healthcare life science employees. Houston’s robust life sciences workforce ranks 12th in the nation, on par with numbers reported for Research Triangle Park. Additionally, Houston compares favorably given its central U.S. location, ample space available and under construction throughout the region, a business friendly environment including accelerated development timelines, and the logistics benefits of  two international airports and the Port of Houston. 

The study finds Houston has the elements necessary to attract key subsectors of the life sciences industry, particularly in cell and gene therapy manufacturing; molecular diagnostics; and biologics drug development and manufacturing.

The study also identifies specific strategies to optimize the region’s “go-to-market” plan to attract more companies in this highly competitive industry.  

These recommendations include accelerating workforce development programs to produce new graduates in key life sciences occupations, refining Houston’s marketing messages to highlight the region’s existing life sciences” assets and activities within life science R&D and manufacturing.  Finally, the study identified the need to develop a shared regional strategy to attract and retain leading life sciences companies. 

The Partnership has assembled task forces to implement the recommendations, which will be led by the organization’s Life Sciences Committee, chaired by Ferran Prat, Senior Vice President of Industry Relations and Research at MD Anderson Cancer Center.

###

Greater Houston Partnership
The Greater Houston Partnership works to make Houston one of the best places to live, work and build a business. As the economic development organization for the region, the Partnership champions growth across 12 counties by bringing together business and civic-minded leaders who are dedicated to the area’s long-term success. Representing 950 member organizations and approximately one-fifth of the region’s workforce, the Partnership is the place companies come together to make an impact. Learn more at Houston.org.

Contact: 
A.J. Mistretta
[email protected] 
504-450-3516

Related News

Life Sciences

Bayou City Bio Pulse: Driving Houston's Life Sciences Growth

12/19/24
Houston's life sciences ecosystem is on the rise, and the Bayou City Bio Pulse is at the heart of this transformation. Launched in fall 2023 by the Greater Houston Partnership’s Life Science Committee, this bi-monthly event series is reshaping how the region's life sciences community connects, innovates and thrives. "Collide to Innovate" Under the motto "Collide to Innovate," Bayou City Bio Pulse aims to bring stakeholders together from across the Greater Houston area to explore the region's leading life sciences hubs. From the Texas Medical Center to Pearland, The Woodlands, and Sugar Land, these events spotlight over 8 million square feet of life sciences and biotechnology spaces, fostering collaboration and showcasing Houston's unparalleled assets. A Platform for Connection and Innovation Each Bayou City Bio Pulse event, organized in collaboration with BioHouston and other committee members, offers unique opportunities for networking, learning, and exploration. Attendees dive into critical topics such as funding, workforce development, artificial intelligence, and the future of innovative workspaces. Complemented by site tours, these gatherings provide an insider’s view into the cutting-edge advancements that are solidifying Houston’s status as a global leader in life sciences and biotechnology. Eric Johnson, Executive Managing Director of National Healthcare Advisory Services at Transwestern, highlights the initiative’s impact: “We’re really excited about what TMC is doing, what the Greater Houston Partnership’s doing and galvanizing our region to propel more life sciences growth here in Houston," said Eric Johnson, Executive Managing Director, National Healthcare Advisory Services, Transwestern. "The efforts of the Partnership’s life sciences committee has made visible strides to boost the cohesiveness and interaction among the many major players in our ecosystem, with opportunities for engagement like the Bayou City Bio Pulse. As we continue to build on successes, we see Houston emerging as a premier destination for life sciences and biotechnology.” Building Momentum Since its debut, Bayou City Bio Pulse has hosted seven events, drawing over 800 participants and doubling attendance from 2023 to 2024. This growing momentum underscores the region’s enthusiasm for collaboration and innovation within the life sciences sector. Shaping Houston’s Future in Life Sciences Looking ahead, the Bayou City Bio Pulse series is poised to amplify its reach and impact. By fostering connections and enhancing awareness of the region's strengths, it continues to support Houston’s evolution as a hub for life sciences and biotechnology. For businesses and innovators in Houston’s life sciences community, Bayou City Bio Pulse is more than an event series—it’s a catalyst for growth and a platform for shaping the future. Learn more about Houston’s life sciences industry.  Download the Partnership's 2024 Impact Report.
Read More
Economic Development

San Jacinto College and CellReady Launch Program to Accelerate Cell Therapy Workforce Development

12/17/24
PASADENA, Texas – The San Jacinto College Center for Biotechnology has partnered with CellReady, a privately held cell therapy contract development and manufacturing organization, to launch an innovative, fast-track training curriculum for new hires in biomanufacturing. This four-week program is designed to significantly shorten onboarding time for manufacturing associates, providing them with concentrated and rigorous hands-on training to jumpstart their readiness to work in advanced cell therapy manufacturing.  Over the course of the program, trainees undergo 160 hours of both theoretical and practical, hands-on learning that cover the fundamentals of biomanufacturing through the operation of advanced workflows. The curriculum prepares new hires for the production of cell therapies, a cutting-edge cancer treatment, using the G-Rex cell production platform. The training, which took place at CellReady’s manufacturing site in Houston, was delivered by San Jacinto College Biotechnology faculty members, in collaboration with CellReady’s training team. “To our knowledge, this is the first collaboration of its kind between a community college and a cell therapy manufacturer to develop an intensive onboarding curriculum tailored specifically for cell therapy manufacturing technicians,” said Dr. Chris Wild, San Jacinto College assistant vice chancellor of biotechnology. “Together with CellReady, we’ve created a path to rapidly train professionals with advanced, hands-on techniques, using the G-Rex cell production platform, which is widely used in the industry today.”  This joint initiative provides clear benefits to all stakeholders. For San Jacinto College, it underscores the institution’s commitment to meeting industry needs with innovative, real-world training.  CellReady gains a streamlined, effective approach to onboarding that enables new technicians to make an immediate impact post-training. At the conclusion of the program, trainees are equipped with the skills and knowledge needed to manufacture cell therapies. Dr. Ignacio Nunez, CellReady’s chief operating officer, was impressed with the training provided and the speed that employees were able to grasp the critical components of the manufacturing process, stating “Thanks to the training program developed and delivered by San Jacinto College and CellReady, we were able to provide our new hires with the essential knowledge and skills to work in a GMP environment. In collaboration with San Jacinto College, we have debottlenecked operator qualification and made great strides toward our mission of bringing more of these life-saving therapies to patients one G-Rex at a time.” “This program not only equips new team members with qualifiable skills to contribute immediately upon completion of the training program, but it also sets a new standard for how training can be delivered in a highly regulated field,” said Dr. Nicole Bradley, program director for the Center for Biotechnology. The program’s success has inspired plans for additional training sessions to onboard future manufacturing professionals at CellReady, further strengthening the relationship between San Jacinto College and CellReady. The training curriculum for cell therapy developed in collaboration with this industry leader will be available as a program offering through the San Jacinto Center for Biotechnology. About CellReady CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About San Jacinto College Surrounded by monuments of history, evolving industries, maritime enterprises of today, and the space age of tomorrow, San Jacinto College has served the people of East Harris County, Texas, since 1961. The College is one of the top 10 community colleges in the nation as designated by the Aspen Institute and was named an Achieving the Dream Leader College of Distinction in 2020. The College is a Hispanic-Serving Institution that spans five campuses, serving approximately 45,000 credit and non-credit students annually. It offers more than 200 degrees and certificates across eight major areas of study that put students on a path to transfer to four-year institutions or enter the workforce. The College is fiscally sound, holding bond ratings of AA+ by Standard & Poor’s and Aa2 by Moody’s.
Read More

Related Events

Executive Partners